StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Swedish Orphan Biovitrum AB (publ)
Stockholm Stock Exchange:SOBI.ST
Sector
Location
Market Cap
USD 10.36 B
Share Price
USD 30.16
Avg Daily Volume
337,805
Change (1 day)
-1.46%
Change (1 year)
15.90%
Change (YTD)
5.21%
Swedish Orphan Biovitrum AB (publ) EBITDA Margin for the year ending December 31, 2024: 35.75%
Swedish Orphan Biovitrum AB (publ) EBITDA Margin is 35.75% for the year ending December 31, 2024, a 9.32% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
-
Swedish Orphan Biovitrum AB (publ) EBITDA Margin for the year ending December 31, 2023 was 32.70%, a 1.51% change year over year.
-
Swedish Orphan Biovitrum AB (publ) EBITDA Margin for the year ending December 31, 2022 was 32.21%, a -12.44% change year over year.
-
Swedish Orphan Biovitrum AB (publ) EBITDA Margin for the year ending December 31, 2021 was 36.79%, a -16.54% change year over year.
-
Swedish Orphan Biovitrum AB (publ) EBITDA Margin for the year ending December 31, 2020 was 44.08%, a 4.41% change year over year.
Competitors
AbbVie Inc.
USD 186.39
ABBV
-5.13
-2.68%
Novo Nordisk A/S
USD 67.17
NOVO-B.CO
-1.94
-2.80%
Roche Holding AG
USD 337.03
RO.SW
-6.82
-1.98%
Novartis AG
USD 119.64
NOVN.SW
-1.19
-0.99%
Abbott Laboratories
USD 131.49
ABT
-0.54
-0.41%
AstraZeneca PLC
USD 140.43
AZN.L
-2.72
-1.90%
Merck & Co., Inc.
USD 81.52
MRK
-2.15
-2.57%
Amgen Inc.
USD 292.51
AMGN
-4.52
-1.52%
Pfizer Inc.
USD 24.61
PFE
-0.74
-2.92%
Gilead Sciences, Inc.
USD 109.06
GILD
-3.03
-2.70%
Vertex Pharmaceuticals Incorporated
USD 464.20
VRTX
-8.15
-1.73%
Sanofi
USD 95.94
SAN.PA
-1.50
-1.54%
Bristol-Myers Squibb Company
USD 46.43
BMY
-0.91
-1.92%
CSL Limited
USD 160.84
CSL.AX
-2.43
-1.49%
GSK plc
USD 18.76
GSK.L
-0.36
-1.89%
Chugai Pharmaceutical Co., Ltd.
USD 45.53
4519.T
-0.47
-1.02%
Regeneron Pharmaceuticals, Inc.
USD 547.96
REGN
-22.63
-3.97%
MERCK Kommanditgesellschaft auf Aktien
USD 127.61
MRK.DE
-0.52
-0.41%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.01
600276.SS
+0.03
0.41%
Takeda Pharmaceutical Company Limited
USD 29.48
4502.T
-0.38
-1.26%
Key Data
| Date | EBITDA Margin | Net Income Margin | EBT Margin | Operating Income Margin |
|---|
Competitors
AbbVie Inc.
USD 186.39
ABBV
-5.13
-2.68%
Novo Nordisk A/S
USD 67.17
NOVO-B.CO
-1.94
-2.80%
Roche Holding AG
USD 337.03
RO.SW
-6.82
-1.98%
Novartis AG
USD 119.64
NOVN.SW
-1.19
-0.99%
Abbott Laboratories
USD 131.49
ABT
-0.54
-0.41%
AstraZeneca PLC
USD 140.43
AZN.L
-2.72
-1.90%
Merck & Co., Inc.
USD 81.52
MRK
-2.15
-2.57%
Amgen Inc.
USD 292.51
AMGN
-4.52
-1.52%
Pfizer Inc.
USD 24.61
PFE
-0.74
-2.92%
Gilead Sciences, Inc.
USD 109.06
GILD
-3.03
-2.70%
Vertex Pharmaceuticals Incorporated
USD 464.20
VRTX
-8.15
-1.73%
Sanofi
USD 95.94
SAN.PA
-1.50
-1.54%
Bristol-Myers Squibb Company
USD 46.43
BMY
-0.91
-1.92%
CSL Limited
USD 160.84
CSL.AX
-2.43
-1.49%
GSK plc
USD 18.76
GSK.L
-0.36
-1.89%
Chugai Pharmaceutical Co., Ltd.
USD 45.53
4519.T
-0.47
-1.02%
Regeneron Pharmaceuticals, Inc.
USD 547.96
REGN
-22.63
-3.97%
MERCK Kommanditgesellschaft auf Aktien
USD 127.61
MRK.DE
-0.52
-0.41%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.01
600276.SS
+0.03
0.41%
Takeda Pharmaceutical Company Limited
USD 29.48
4502.T
-0.38
-1.26%